Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.37 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6711699 | 0.95 | CNR2 (0.44) | CNR2ALDH1A1TSHRHTTKDM1A | |
| SCHEMBL6713883 | 0.94 | CNR2 (0.46) | CNR2ALDH1A1TSHRHTTTRPA1 | |
| SCHEMBL6914601 | 0.94 | CNR2 (0.45) | CNR2ALDH1A1TSHRHTTTRPA1 | |
| SCHEMBL6711776 | 0.93 | ROCK2 (0.39) | CNR2ALDH1A1TSHRHTTKDM1A | |
| SCHEMBL6710046 | 0.92 | HDAC3 (0.41) | CNR2ALDH1A1TSHRHTTKDM1A | |
| SCHEMBL6710330 | 0.89 | CNR2 (0.39) | CNR2ALDH1A1TSHRHTTKDM1A | |
| SCHEMBL6711975 | 0.89 | TRPA1 (0.46) | KDM1ATRPA1ROCK2GRM4 | |
| SCHEMBL6710061 | 0.89 | CNR2 (0.45) | CNR2ALDH1A1TSHRHTTTRPA1 | |
| SCHEMBL6714431 | 0.88 | ROCK1 (0.46) | CNR2TSHRPTGDR2CNR1 | |
| SCHEMBL6709924 | 0.87 | CNR2 (0.37) | CNR2ALDH1A1TSHRHTTTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
| WO-2004018461-A2 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | CNR2 3985/4885ALDH1A1 123/4885TSHR 3901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.